Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| UCLA Prostate Cancer Index× | FACT-Lung: Functional Assessment of Cancer Therapy× | |
|---|---|---|
| Campo | Oncologia | Oncologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1998 | 1995 |
| Ideatore≠ | Litwin, M. S., et al. | David F. Cella, Ph.D. |
| Tipo | Self-report questionnaire | Self-report questionnaire |
| Fonte seminale≠ | Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗ | Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153. link ↗ |
| Alias≠ | UCLA PCI, PCI | FACT-L |
| Correlati | 5 | 5 |
| Sintesi≠ | The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes. | The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden. |
| ScholarGateInsieme di dati ↗ |
|
|